Korean J Urol.  2007 Jun;48(6):638-645. 10.4111/kju.2007.48.6.638.

A Recent Study on the Antimicrobial Sensitivity of the Organisms that Cause Urinary Tract Infection

• Ryu KH
• Kim MK
• Jeong YB

• KMID: 1885547
• DOI: http://doi.org/10.4111/kju.2007.48.6.638

Abstract

PURPOSE: The overuse and misuse of antimicrobial agents have made choosing an appropriate antibiotic more difficult. We studied changes in the antibiotic sensitivities of the causative microorganisms of urinary tract infection (UTI), in 2000 versus 2005, in order to provide useful information and to aid physicians to make better choices of adequate drugs for treating UTI.
MATERIALS AND METHODS
We retrospectively analyzed 5,266 uropathogens and their antimicrobial sensitivities in 3,346 patients who were admitted to or they had visited two tertiary hospitals located in Honam province, in 2000 versus 2005. This revealed the isolated causative organisms in the urine cultures.
RESULTS
The incidence of UTI shows bimodal peaks in the first decade (22.3%) and 7th decade (18.8%). The common pathogens were E. coli (34.4%), Enterococcus (19.0%), Staphylococcus (10.2%), Pseudomonas (9.9%) and Klebsiella (9.8%). The incidence of Gram positive organisms was increased from 35.7% in 2000 to 38.1% by 2005. For the Gram negative isolates, imipenem and amikacin showed relatively higher sensitivity, while ampicillin and ciprofloxacin showed relatively lower sensitivity. For the Gram positive isolates, vancomycin and teicoplanin showed relatively higher sensitivity, while penicillin and ciprofloxacin showed relatively lower sensitivity. Significant declines for the third-generation cephalosporins' and fluoquinolones' sensitivity to E. coli and Klebsiella isolates were found.
CONCLUSIONS
E. coli was the most common single organism causing UTI. We should be concerned about the increase of Gram positive organisms, especially Enterococcus. The use of TMP/SMX and nitrofurantoin as the first choices of treatment for UTI should be reconsidered. It is recommended that fluoroquinolone should be restricted because of the high antibiotic resistance and the economic aspects.

Keyword

Urinary tract infection; Antibiotics; Sensitivity

MeSH Terms

Amikacin
Ampicillin
Anti-Bacterial Agents
Anti-Infective Agents
Ciprofloxacin
Drug Resistance, Microbial
Enterococcus
Humans
Imipenem
Incidence
Klebsiella
Nitrofurantoin
Penicillins
Pseudomonas
Retrospective Studies
Staphylococcus
Teicoplanin
Tertiary Care Centers
Urinary Tract Infections*
Urinary Tract*
Vancomycin
Amikacin
Ampicillin
Anti-Bacterial Agents
Anti-Infective Agents
Ciprofloxacin
Imipenem
Nitrofurantoin
Penicillins
Teicoplanin
Vancomycin

Figure

• 

  Fig. 1. Age and gender distribution of the urinary tract infections.

Reference

References

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113(Suppl 1A):S5–13.

2. Engel JD, Schaeffer AJ. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol Clin North Am. 1998; 25:685–701.

3. Kunin CM. An overview of urinary tract infection. Kunin CM, editor. Urinary tract infection: detection, prevention and management. 5th ed.Baltimore: Williams & Wilkins;1998. p. 2–21.

4. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997; 11:551–81.

5. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001; 183:S1–4.

6. Nicolle LE. Epidemiology of urinary infection. Infect Med. 2001; 18:153–62.

7. Muratani T, Matsumoto T. Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents. 2004; 2(Suppl 1):S28–31.

8. Ko HS, Choi DY, Han YT. A study of the changes of antibiotic sensitivity to the causative organisms of urinary tract infection for recent 5 years. Korean J Urol. 1999; 40:809–16.

9. Ko YH, Oh JS, Cho DY, Bea JH, Koh SK. Changes of causative organisms and antimicrobial sensitivity of urinary tract infection between 1979 and 2001. Korean J Urol. 2003; 44:342–50.

10. Song HJ, Kim SJ. A study of antimicrobial sensitivity to the causative organism of urinary tract infection. Korean J Urol. 2005; 46:68–73.

11. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999; 29:745–58.

12. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 2001; 135:41–50.

13. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatient in the United States. Antimicrob Agents Chemother. 2002; 46:2540–5.

14. Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years. Int J Antimicrob Agents. 2005; 26:75–7.

15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 11th informational supplement. Waync, Pa: NCCLS;2001. p. 100–11.

16. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, et al. Increasing resistance to fluoroquinolones in escherichia coli from urinary tract infections in the netherlands. J Antimicrob Chemother. 2000; 46:223–8.

17. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med. 1999; 14:606–9.

18. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Factors associated with trimethoprim-resistant bacteria isolated from urine samples. J Antimicrob Chemother. 1999; 43:841–3.

19. Alos JI, Serrano MG, Gomez-Garces JL, Periances J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect. 2005; 11:199–203.